Skip to content

Clinical trials

Observational Cystic Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Observational Clear all

500 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20018
20031
20047
20054
200612
200711
200812
200913
201015
201119
201214
201328
201428
201526
201619
201726
201829
201934
202026
202141
202225
202330
202426
202521
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed289
Unknown status82
Recruiting67
Active, not recruiting22
Terminated15
Withdrawn10
Not yet recruiting8
Enrolling by invitation6
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon22
National Jewish Health13
Assistance Publique - Hôpitaux de Paris12
Hacettepe University10
Boston Children's Hospital8
University of British Columbia8
Children's Hospital Medical Center, Cincinnati7
Children's Hospital of Philadelphia7
National Heart, Lung, and Blood Institute (NHLBI)7
University of North Carolina, Chapel Hill7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis500
Asthma28
Pulmonary Disease, Chronic Obstructive24
Diabetes Mellitus19
Lung Diseases18
Pseudomonas Infections14
Breast Neoplasms13
Bronchiectasis12
Ciliary Motility Disorders12
Inflammation11

Trials

Showing 51 to 75 of 500. Each trial links to its page on Pharma Observatory.

400 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.